FBXO32 activates NF-κB through IκBα degradation in inflammatory and genotoxic stress

Area of Science:

• Cellular biology
• Molecular mechanisms of stress response
• Signal transduction pathways

Background:

• The canonical Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway is crucial for cellular protection and genomic integrity.
• Activation of the NF-κB pathway involves the proteasomal degradation of its inhibitor, IκBα.
• Previous studies indicated a limited role for F-box protein βTRCP1 in IκBα degradation during stress.

Purpose of the Study:

• To identify novel regulators of the NF-κB signaling pathway during stress conditions.
• To investigate the role of F-box proteins beyond βTRCP1 in NF-κB activation.
• To elucidate the function of FBXO32 in the context of genotoxic and inflammatory stress responses.

Main Methods:

• Investigating the stabilization of FBXO32 upon genotoxic or inflammatory stress.
• Analyzing the polyubiquitination and proteasomal degradation of IκBα mediated by FBXO32.
• Assessing the requirement of FBXO32 for physiological regulation of IκBα levels in unstressed cells.

Main Results:

• FBXO32 is stabilized following genotoxic or inflammatory stress.
• Stabilized FBXO32 promotes polyubiquitination and proteasomal degradation of IκBα.
• FBXO32 is essential for maintaining physiological IκBα levels even in the absence of stress.

Conclusions:

• FBXO32 acts as a novel activator of the NF-κB signaling pathway.
• FBXO32 plays a significant role in regulating IκBα degradation under both stressed and unstressed conditions.
• This study uncovers a new regulatory mechanism within the NF-κB pathway involving FBXO32.